TEACHERS ADVISORS, LLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.8%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2018$2,355,000
+122.4%
1,010,601
+171.1%
0.00%
+200.0%
Q4 2017$1,059,000
+28.2%
372,815
+29.0%
0.00%0.0%
Q3 2017$826,000
+16.0%
288,905
+0.3%
0.00%0.0%
Q2 2017$712,000
+12.8%
288,073
+64.9%
0.00%0.0%
Q1 2017$631,000
+6.4%
174,705
+4.3%
0.00%0.0%
Q4 2016$593,000
-11.6%
167,582
+0.9%
0.00%0.0%
Q3 2016$671,000
-7.3%
166,149
+0.7%
0.00%0.0%
Q2 2016$724,000
+20.7%
164,942
+3.9%
0.00%0.0%
Q1 2016$600,000
-90.9%
158,794
-62.3%
0.00%
-91.7%
Q4 2015$6,613,000
+79.7%
421,746
+20.8%
0.01%
+71.4%
Q3 2015$3,680,000
-58.1%
349,140
+0.3%
0.01%
-56.2%
Q2 2015$8,780,000
-9.0%
348,135
+0.5%
0.02%
-11.1%
Q1 2015$9,651,000
+153.2%
346,301
+65.8%
0.02%
+157.1%
Q4 2014$3,812,000
+40.8%
208,8900.0%0.01%
+40.0%
Q3 2014$2,707,000
-20.4%
208,890
+0.2%
0.01%
-28.6%
Q2 2014$3,402,000
-9.3%
208,470
-1.8%
0.01%
-12.5%
Q1 2014$3,749,000
-26.3%
212,195
+1.0%
0.01%
-27.3%
Q4 2013$5,088,000
+29.9%
210,148
+90.0%
0.01%
+10.0%
Q3 2013$3,918,000
+134.6%
110,578
+3.4%
0.01%
+150.0%
Q2 2013$1,670,000106,9840.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2018
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 1,025,000$24,815,00031.36%
TSP Capital Management Group, LLC 836,342$20,248,0008.80%
Iguana Healthcare Management, LLC 200,000$4,842,0002.76%
First Light Asset Management, LLC 116,096$2,811,0002.38%
SECTORAL ASSET MANAGEMENT INC 2,227,688$53,932,0002.33%
BENNETT LAWRENCE MANAGEMENT L L C/NY 550,735$13,334,0002.05%
Eventide Asset Management 257,000$6,222,0001.92%
Redmile Group, LLC 397,951$9,634,0001.19%
ARDSLEY ADVISORY PARTNERS LP 357,000$8,643,0001.15%
Rhenman & Partners Asset Management AB 90,000$2,179,0000.85%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders